I can't imagine the fully diluted shares exceeding 45 million when commercialization happens. The average cost for a company to get Premarket Approval from the FDA is about $130 AUD (depending on the exchange rate). With the fully diluted right now at about 15 million shares, another 30 million shares at $9 would bring in $270 million, which should easily get us there.
This is assuming Anteris goes it alone and doesn't enter into a partnership or get bought out. Obviously with a partnership we'd get less dilution but have to give up a royalty so one way or another there will be a cost but I think it's very probable we don't exceed 45 million shares and may wind up with a good bit less once DurAVR revenue start being generated.
- Forums
- ASX - By Stock
- AVR
- AVRO
AVRO, page-372
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$14.00 |
Change
0.000(0.00%) |
Mkt cap ! $295.9M |
Open | High | Low | Value | Volume |
$14.10 | $14.41 | $13.73 | $535.0K | 38.28K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 935 | $14.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.20 | 60 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 935 | 14.000 |
1 | 500 | 13.850 |
1 | 100 | 13.800 |
1 | 1000 | 13.700 |
1 | 500 | 13.520 |
Price($) | Vol. | No. |
---|---|---|
14.200 | 60 | 1 |
14.400 | 115 | 1 |
14.420 | 500 | 1 |
14.500 | 1000 | 1 |
15.500 | 370 | 1 |
Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online